News
-
-
PRESS RELEASE
Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation
Phase III GRAPPA trial results show ATLG (Grafalon®) superiority in unrelated donor stem cell transplantation. Lower mortality and infection rates support its continued use as standard care -
-
-
-
-
-
PRESS RELEASE
Giotto.ai and KPS AG join forces to bring Giotto.ai’s breakthrough, sovereign and portable technology to European enterprise clients
Giotto.ai and KPS AG partner to bring breakthrough AI technology to European enterprise clients, offering advanced AI reasoning and enterprise-grade capabilities -
-